Related Experiment Videos
Hypertension management in patients with diabetic nephropathy
1University of Virginia Health System, Center for Diabetes & Hormone Excellence, Endocrinology Division, 450 Ray C. Hunt Drive, PO Box 801407, Charlottesville, VA 22908, USA. alm3j@virginia.edu
Insights
Managing hypertension in diabetic nephropathy is key to delaying kidney failure. Combining therapies and monitoring proteinuria are crucial for better patient outcomes and preventing dialysis.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Diabetic nephropathy management prioritizes controlling hypertension to slow proteinuria and kidney failure.
- Renin-angiotensin system blockers are initial treatments for hypertension in early nephropathy.
- Limited data exist on the impact of antihypertensive drug combinations on hard clinical outcomes like dialysis or death.
Purpose of the Study:
- To review current strategies for hypertension management in diabetic nephropathy.
- To highlight the need for better understanding of antihypertensive drug combination effects on renal and cardiovascular outcomes.
- To emphasize individualized treatment approaches based on disease stage and patient factors.
Main Methods:
- Literature review focusing on hypertension management in diabetic nephropathy.
- Analysis of studies examining antihypertensive drug combinations and their impact on proteinuria, kidney function, and mortality.
- Discussion of therapeutic strategies beyond direct hypertension control.
Main Results:
- Patients often require multiple antihypertensive drugs, with control becoming more challenging as nephropathy progresses.
- Quantitative proteinuria tracking is suggested to guide therapy.
- A comprehensive approach focusing on cardiovascular and renal endpoints is vital.
Conclusions:
- Individualized hypertension management strategies are essential, considering disease stage, comorbidities, and age.
- Therapies targeting factors beyond hypertension can significantly improve outcomes.
- Further research is needed on the long-term effects of antihypertensive drug combinations on hard clinical outcomes.
Abstract:
Treatment of hypertension, to reverse and delay proteinuria progression and kidney failure, is the primary focus of medical management in patients with diabetic nephropathy. The initial choice for hypertension treatment in those with early nephropathy involves agents that block the renin-angiotensin system. However, it is not clear what the best choices for further drug therapy management are, because there are few data concerning the impact that antihypertensive drug combinations have on hard clinical outcomes, such as preventing the need for dialysis, and death. Patients usually require several drugs for controlling hypertension, which becomes harder to control as nephropathy progresses. In this review, it is suggested that quantitatively tracking proteinuria to guide therapy and a broad focus on the cardiovascular and renal end points are important for best outcomes in patients. Strategies may vary based on stage of disease, comorbidities, and age. Therapies not directed specifically at hypertension may also significantly aid hypertension management in prevention of progressive nephropathy, comorbidities, and mortality.
Related Concept Videos
Hypertension V: Nursing Management
Diabetic Nephropathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease IV: Nursing Management